http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427528-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40285e27f4ed83b8728b0d477404958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b59cb06598c41ca93b7ff9515053ca12
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-738
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-738
filingDate 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce3c9aec05562c07c085ab289ed99f02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b094f6bf5a446d06a2e27759d85fbbf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ffd4c058a341c38eb5c45a27e15467
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49d1be3cf79c0bde8f349fac71d7e586
publicationDate 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11427528-B2
titleOfInvention Fenofibrate crystalline form and manufacturing method thereof
abstract The present invention relates to Form IV of fenofibrate and its preparation methods thereof. Its X-ray powder diffraction pattern expressed as 2θ angle has characteristic peaks at 14.15±0.2°, 15.94±0.2°, 16.49±0.2°, 17.45±0.2°, 20.21±0.2°, and 22.87±0.2°. The present invention also provides preparation methods of Form IV. The preparation methods are simple, easy to operate, short, and have good repeatability. The methods are also non-toxic and non-polluting by using water as a medium and using a pharmaceutically accepted excipient, such as polyvinylpyrrolidone or polyvinyl alcohol as an inducer. The results of stability experiments (light exposure, high humidity and grinding) and solubility tests show that Form IV is stable and has a higher solubility than the prior art crystal form.
priorityDate 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2170801-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4739101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014187229-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445715-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452450317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67474962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427841954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11506004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426179543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 37.